-
Small Cell Lung Cancer Market Research 2025-2035, Competitive Analysis of Amgen, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Genentech, Merck, Pfizer, PharmaMar, Sun Pharma, Teva - ResearchAndMarkets.com
23 Oct 2025 15:37 GMT
… -centric care.
Companies Featured
Amgen
AstraZeneca
Boehringer Ingelheim
Bristol-Myers Squibb … Analysis
1.4 Patent Analysis
1.4.1 Patent Filing Trend (by … Country)
1.4.2 Patent Filing Trend (by Year)
1 …
-
AstraZeneca Bolsters Oncology with £1.2 Billion Fusion Buyout Amid UK Growth
22 Oct 2025 12:48 GMT
… existing radioconjugate pipeline of AstraZeneca, such as Enhertu, … biotech to deal with patent cliffs.
Larger Implications for … nature of healthcare, with AstraZeneca being a leading constituent. … strengthens the pipeline of AstraZeneca but also highlights the …
-
Here’s when the next stock market crash will happen, according to this billionaire investor!
25 Oct 2025 10:40 GMT
… of sudden, unexpected volatility.
Take AstraZeneca (LSE:AZN) as a prime … ’s currently facing a troubling patent cliff with many blockbuster drugs … over the next five years. AstraZeneca’s development pipeline helps offset …
-
Fierce Pharma Asia—Licensing deal flow, China crackdown warning and ESMO readouts
24 Oct 2025 20:13 GMT
… medicine Entyvio creeps toward its patent cliff.
At Fierce Biotech Week … company’s ADC alliance with AstraZeneca yielded two more impressive showings …
-
At a gathering of biopharma executives, a moment of wonder — and also of worry
24 Oct 2025 19:40 GMT
… . But deals between Pfizer and AstraZeneca and the administration include promises … in its Medicare program before patents expire could mean less investment …
-
Nivolumab outperforms ipilimumab for advanced melanoma
24 Oct 2025 17:24 GMT
… . Blank reports advisory roles with AstraZeneca, Bristol Myers Squibb, Eli Lilly … ; cofounding Flindr Therapeutics; and various patents.
Add topic to email alerts …
-
Dupixent stirs Sanofi’s growth as vaccine sales cool
24 Oct 2025 16:26 GMT
… the drug expected to lose patent protection in 2031. In that … Q3 conference call.
Pfizer and AstraZeneca became the first major pharma …
-
Harnessing AI for Drug Discovery: The Race to Innovate and Govern
24 Oct 2025 14:42 GMT
… screening drug candidates. AstraZeneca was able to reduce … patents. Multibillion-dollar deals between global pharmaceutical giants—Sanofi, Pfizer, AstraZeneca … patents. Multibillion-dollar deals between global pharmaceutical giants—Sanofi, Pfizer, AstraZeneca …
-
Actinium Pharmaceuticals Presents New Data Demonstrating Potent and Durable Efficacy of ATNM-400, a First-in-Class Multi-Tumor Actinium-225 Radiotherapy, at the 32nd Annual Prostate Cancer Foundation Scientific Retreat
24 Oct 2025 12:47 GMT
… overcome resistance to osimertinib (TAGRISSO®, AstraZeneca) an EGFR-TKI therapy in … . The EGFR TKI Osimertinib (TAGRISSO, AstraZeneca) generated sales of $6.6 … holds approximately 240 patents and patent applications including several patents related to the …
-
The predictive validity crisis: Pharma’s productivity paradox – Part II
24 Oct 2025 10:35 GMT
… from Vertex, Regeneron and AstraZeneca illustrate how aligning biology, … a coherent predictive system.
AstraZeneca has taken a different … systematically addressing each domain, AstraZeneca reduces the errors and … and has twelve issued patents. In 2003, he …
About
© 1995-2025